Chairman Emeritus, Board of Directors; Outside Director to the Board; and founder of Lachman Consultants.  During his more than 40 years’ experience in the pharmaceutical industry, he has been at the forefront in the shift from the trial and error approach of dosage form development to the scientific approach to dosage form design.  He has […]

Outside Director to the Board at Lachman Consultants. Dr. Chow has over 25 years of experience in the pharmaceutical industry, having held positions of increasing levels of responsibility, including executive-level positions in research and development for new and generic drugs, analytical chemistry, quality control/assurance, and regulatory compliance. During his tenure at Lachman Consultants, he has […]

Senior Advisor, Outside Director to the Board at Lachman Consultants.  He joined Lachman Consultants following a distinguished career with the FDA and the Public Health Service.  His FDA experience, culminating as the Acting Deputy Director of the Office of Generic Drugs, enables him to provide expert advice and assistance on all aspects of FDA and […]

Rebecca (Becky) Welton is a Senior Associate in the Regulatory Practice at Lachman Consultants who is an experienced Science, Operations, and Regulatory leader with 25+ years in the pharmaceutical industry holding positions of escalating accountabilities in chemistry, formulation, management, pilot plant manufacturing, and regulatory affairs. She is well-versed in areas of solid dosage generic product […]

Senior Associate, is an Analytical, Bioanalytical and Quality Control Laboratory Specialist experienced in auditing R&D, Stability, Bioanalytical, and Quality Control laboratories under state, federal and corporate policies.  She has over 18 years of pharmaceutical and consulting experience and brings a solid working knowledge of different audit types including cGMP, API, PAI and CRO bioanalytical laboratories.  Ms. […]

Principal Consultant in the Regulatory Practice of Lachman Consultants with 20+ years’ experience as a Regulatory professional in the pharmaceutical industry. With her expert knowledge of pharmaceutical regulations, standards, current industry practices, and strong practical experience, she delivers strategic leadership to Lachman’s clients, including for ANDA, NDA, and IND, [505(j), 505(b)(1) and 505(b)(2)] applications as […]

Associate Director in the Science and Technology practice at Lachman Consultants and an accomplished Quality Assurance professional with over twenty years of experience in pharmaceutical research from both a sponsor and Contract Research Organization (CRO) perspective. He has extensive QA experience in all aspects of Clinical (GCP) and Preclinical (GLP) studies and experience with Manufacturing […]

Director in the Science and Technology Practice at Lachman Consultants who is a seasoned CMC pharmaceutical / biopharmaceutical professional with more than 27 years directing CMC activities, leading analytical chemistry teams, addressing compliance gaps, compliance department leadership with P&L responsibility, implementing process excellence initiatives, developing pharmaceutical product stability operations, and CMC project management. Dr. Rhines […]

Scott Deckebach, M.B.A., is a Director in the Compliance Practice at Lachman Consultants with more than 25 years of experience in the life sciences including APIs, pharmaceuticals (RX and OTC) biopharmaceuticals, aseptics, and medical devices. Mr. Deckebach has extensive quality systems design and remediation experience. He develops IT strategies and solutions and is a Computer […]

Director in the Compliance Practice at Lachman Consultants who has extensive R&D Quality, and Quality Operations experience in the pharmaceutical industry. Dr. Toro specializes in the transformation of Quality and Technical Services organizations including Quality Systems, global implementations, corporate auditing, technology transfer and plant operations. He has a broad knowledge of regulatory compliance and quality […]